Featured Posts

Sunday, February 10, 2019

Neurotrope to Participate in the BIO CEO & Investor Conference

NEW YORK, Feb. 8, 2019 /PRNewswire/ -- Neurotrope Inc. (NASDAQ: NTRP), a clinical-stage biopharmaceutical company developing novel therapies for neurodegenerative diseases, including Alzheimer's disease (AD), today announced that Charles Ryan, J.D., Ph.D., Neurotrope's Chief Executive...

from PR Newswire: https://prn.to/2tdjUNe

No comments:

Post a Comment